Degree | Type | Year | Semester |
---|---|---|---|
4313794 Biochemistry, Molecular Biology and Biomedicine | OT | 0 | A |
This module aims to approach the students to the functioning of research in a tertiary hospital, by showing the different medical states from diagnostic to care of diseases.
The aim of the module is to enable students to acquire the basic knowledge on the ethical, methodological, regulatory and logistical aspects used in translational and clinical research, to be able to plan experiments in human pathology based on Genomics, Proteomics, Cytomics and Metabolomics, to acquire the knowledge to identify the transferability of the results of their research to the market, and to understand the bases and the application of new diagnostic tools (massive sequencing, magnetic resonance imaging, microarrays, nanotechnology, etc.) and advanced therapies in human pathology.
SECTION 1: INTRODUCTION TO CLINICAL PRACTICE IN THE HOSPITAL ENVIRONMENT.
1.1. Where are you? Introduction to Campus Vall d’Hebron and the Health System in Catalonia.
1.2. Module’s Introduction. Open questions.
1.3 Diagnosis Units. Transversal Facilities/Services. MICRO/AP/IMMUNO/GENETICA
1.4. Pharmacology and pharmacy
1.5. Research models in surgery
SECTION 2: CLINICAL RESEARCH AND CLINICAL TRIALS.
2.1. Methodologies for Clinical Research.
2.2. Operational aspects. How to manage with clinical trials. Most frequent problems
2.3. Observational epidemiologic studies: Design, advantages and disadvantages. Principal bias
2.4. Clinical trials. Legal and ethical issues of clinical research
SECTION 3: CORE FACILITIES FOR RESEARCH. Visit to Core Facilities
Visit to Central Laboratories HUVH
SECTION 4: TOOLS FOR DIAGNOSIS IN HUMAN PATHOLOGY. GENOMICS.
4.1. NGS for Virus research and diagnosis (Hepatitis A, B, D & E virus)
4.2. HCV from basic research to the diagnosis. Example of translational research.
4.3. Massive Sequencing in Exosomes and Liver disease follow up
4.4. Use of sequencing technologies to investigate the human microbiome
4.5. Research tools in dementia and other neurodegenerative disorders
4.6. Biomarkers for the Diagnosis of Diseases
SECTION 5: TOOLS FOR ADVANCED THERAPIES. CELLS, PROTEOMICS & NANOPARTICLES. Jordi Barquinero / Ibane Abasolo
5.1. Tools to study cellular organelle dysfunction
5.2. Proteomics, a general purpose tool for the biomedical research laboratory
5.3. Advanced Therapies. Gene Therapy. Stem Cells.
5.4. Therapies with mesenchymal cells
5.5. Immunotherapy
5.6. Cell therapy for fetal repair
5.7. General Introduction to Nanomedicine. Drug delivery systems
5.8. Inorganic Nanoparticles with applications in medicine
5.9. Clinical genetics. Cytogenetic Prenatal Diagnosis: past and present trends
5.10. Liquid biopsy for prenatal diagnosis
Evaluation: Oral presentations
Theoretical classes. Discussion of problems in class. Visit laboratories. Stimulate the interest of the students to solve real or putative clinical problems. Reading articles to propose a team based research project. Discussion of projects.
Title | Hours | ECTS | Learning Outcomes |
---|---|---|---|
Type: Directed | |||
Theory clases | 65 | 2.6 | 1, 5, 7, 6, 9 |
Type: Supervised | |||
Mentoring | 3 | 0.12 | 4, 3, 5, 7, 6, 8, 2, 9, 10, 11 |
Type: Autonomous | |||
Study | 154 | 6.16 | 1, 4, 3, 5, 7, 6, 8, 2, 9, 10, 11 |
Writing a project based on a clinical problem (team work) 30%
Defence of the project in front of all the students and evaluators 35%
Test exam 35%
Attending a minimum of 80% of the classes is required for taking the exam and passing the course.
To be eligible for the retake process, the student should have been previously evaluated in a set of activities equaling at least two thirds of the final score of the course or module. Thus, the student will be graded as "No Avaluable" if the weighthin of all conducted evaluation activities is less than 67% of the final score
Title | Weighting | Hours | ECTS | Learning Outcomes |
---|---|---|---|---|
Delivery of research project | 30% | 0 | 0 | 1, 4, 5, 7, 6, 8, 2, 9 |
Oral presentation of the project | 35% | 1 | 0.04 | 1, 4, 3, 5, 7, 6, 8, 2, 9, 11 |
Test exam | 35% | 2 | 0.08 | 4, 3, 5, 7, 2, 9, 10, 11 |
At the Bench: A Laboratory Navigator. Updated Edition. Kathy Barker. Cold Sprinh Harbor Laboratory Press, Cold Spring Harbor, New York, 2005.
GeneReviews (http://www.ncbi.nlm.nih.gov/books/NBK1116/)
Edited by Roberta A Pagon, Editor-in-chief, Thomas D Bird, Cynthia R Dolan, and Karen Stephens. Seattle (WA): University of Washington, Seattle; 1993-.
Molecular Diagnostics: Techniques and Applications for the Clinical Laboratory. 2009. Edited by: George P. Patrinos and Wilhelm J. Ansorge. 2nd ed. p. 616. Academic Press. 1st ed. p. 736. Academic Press.
Molecular Pathology: The Molecular Basis of Human Disease. 2009. 1st ed. p. 664. Academic Press.
Transforming Clinical Research in the United States: Challenges and Opportunities, Workshop Summary, Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies, The National Academies Press, Washington D.C. http://fastercures.org/train/resources/documents/TransformingClinicalResearchintheUnitedStates.pdf
Biotecnología Aplicada a la Identificación y Validación de Dianas Terapéuticas. Informe de Vigilancia Tecnológica, Genoma España, http://www.gen-es.org/12_publicaciones/docs/pub_73_d.pdf
Impacto de la Biotecnología en el sector Sanitario (SECURED), 1er Informe de Propspectiva Tecnológica, Genoma España http://www.gen-es.org/12_publicaciones/docs/pub_63_d.pdf
The Human Protein Atlas ( www.proteinatlas.org)